Nicotine, as a novel tolerogenic adjuvant, enhances the efficacy of immunotherapy in a mouse model of allergic asthma

• Autores principales: Ebrahim Mazloomi (Autor), Behrooz Ilkhanizadeh (Autor), Ahad Zare (Autor), Adel Mohammadzadeh (Autor), Nowruz Delirezh (Autor), Shahram Shahabi (Autor)
• Formato: Libro
• Publicado: Wolters Kluwer Medknow Publications, 2019-01-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

An increasing trend in the incidence of allergic diseases including asthma and related morbidity and mortality is observed worldwide during the last decades. Allergen-specific immunotherapy is suggested for the treatment of some allergic diseases; nevertheless, there is always a menace of uncommon,...